Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Besser G. M., Wass J. A. Pleuropulmonary shadows on bromocriptine. Lancet. 1981 Feb 7;1(8215):323–323. doi: 10.1016/s0140-6736(81)91927-9. [DOI] [PubMed] [Google Scholar]
- Graham J. R. Cardiac and pulmonary fibrosis during methysergide therapy for headache. Am J Med Sci. 1967 Jul;254(1):1–12. doi: 10.1097/00000441-196707000-00001. [DOI] [PubMed] [Google Scholar]
- Grimes J. D., Hassan M. N. Bromocriptine in the long-term management of advanced Parkinson's disease. Can J Neurol Sci. 1983 May;10(2):86–90. doi: 10.1017/s0317167100044693. [DOI] [PubMed] [Google Scholar]
- Hindle W., Posner E., Sweetnam M. T., Tan R. S. Pleural effusion and fibrosis during treatment with methysergide. Br Med J. 1970 Mar 7;1(5696):605–606. doi: 10.1136/bmj.1.5696.605. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Le Witt P. A., Calne D. B. Recent advances in the treatment of Parkinson's disease: the role of bromocriptine. J Neural Transm. 1981;51(1-2):175–184. doi: 10.1007/BF01664014. [DOI] [PubMed] [Google Scholar]
- Pleuropulmonary changes during long-term bromocriptine treatment for Parkinson's disease. Lancet. 1981 Jan 3;1(8210):44–45. [PubMed] [Google Scholar]
- Pleuropulmonary changes during long-term bromocriptine treatment for Parkinson's disease. Lancet. 1981 Jan 3;1(8210):44–45. [PubMed] [Google Scholar]
- Schild H. O. Some aspects of receptor pharmacology of ergotamine. Postgrad Med J. 1976;52SUPPL:9–11. [PubMed] [Google Scholar]
- Vergeret J., Barat M., Taytard A., Bellvert P., Domblides P., Douvier J. J., Fréour P. Fibrose pleuro-pulmonaire et bromocriptine. Sem Hop. 1984 Mar 8;60(11):741–744. [PubMed] [Google Scholar]